AIM
REGN icon

Assured Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Assured Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,508
Closed -$1.31M – 1324
2018
Q4 		$1.31M Buy
3,508
+1,589
+83% +$582K 0.04% 406
2018
Q3 		$775K Buy
1,919
+908
+90% +$346K 0.01% 634
2018
Q2 		$349K Buy
+1,011
New +$316K 0.01% 910
2017
Q3 		– Sell
-2,322
Closed -$1.14M – 672
2017
Q2 		$1.14M Buy
2,322
+1,166
+101% +$510K 0.02% 368
2017
Q1 		$448K Sell
1,156
-704
-38% -$261K 0.01% 443
2016
Q4 		$683K Buy
1,860
+1,311
+239% +$499K 0.01% 397
2016
Q3 		$221K Sell
549
-4,017
-88% -$1.61M 0.01% 505
2016
Q2 		$1.59M Buy
4,566
+2,681
+142% +$1.03M 0.04% 182
2016
Q1 		$679K Buy
1,885
+906
+93% +$373K 0.01% 272
2015
Q4 		$531K Buy
+979
New +$530K 0.01% 288
2015
Q3 		– Sell
-69
Closed -$35K – 699
2015
Q2 		$35K Buy
+69
New +$33.7K ﹤0.01% 614

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Assured Investment Management's REGN Position: Q1 2019 in Review

Assured Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q1 2019, closing a stake of 3,508 shares — an estimated $1.31M sold.

Assured Investment Management first reported a position in REGN in Q2 2015 and held it in 11 quarters. The position peaked at $1.59M in Q2 2016. 719 funds tracked by Wall St. Rank hold REGN as of Q1 2019.

  • Assured Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Assured Investment Management sold 3,508 Regeneron Pharmaceuticals shares in Q1 2019, an estimated $1.31M.
  • Assured Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2015 and held it in 11 quarters.
  • Assured Investment Management's Regeneron Pharmaceuticals position peaked at $1.59M in Q2 2016.
  • 719 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2019.

Based on Assured Investment Management's 13F filing for Q1 2019, filed 16 May 2019.